[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "610 725 1500", "website": "https://www.galeratx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy that is in Phase 2a clinical trial. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. J. Mel Sorensen M.D.", "age": 67, "title": "CEO, President & Chairman", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 633279, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joel F. Sussman CMA, CPA", "age": 75, "title": "Chief Accounting Officer, Secretary & Treasurer", "yearBorn": 1949, "fiscalYear": 2024, "totalPay": 349440, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.024, "open": 0.0235, "dayLow": 0.0235, "dayHigh": 0.0235, "regularMarketPreviousClose": 0.024, "regularMarketOpen": 0.0235, "regularMarketDayLow": 0.0235, "regularMarketDayHigh": 0.0235, "payoutRatio": 0.0, "forwardPE": -0.02016129, "volume": 5993, "regularMarketVolume": 5993, "averageVolume": 140925, "averageVolume10days": 107260, "averageDailyVolume10Day": 107260, "bid": 0.0237, "ask": 0.0245, "bidSize": 78435, "askSize": 10000, "marketCap": 1886559, "fiftyTwoWeekLow": 0.015, "fiftyTwoWeekHigh": 0.06, "allTimeHigh": 19.5, "allTimeLow": 0.015, "fiftyDayAverage": 0.02042, "twoHundredDayAverage": 0.0268, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 151001824, "profitMargins": 0.0, "floatShares": 44118332, "sharesOutstanding": 75462390, "sharesShort": 2123783, "sharesShortPriorMonth": 2657537, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.039, "heldPercentInsiders": 0.32694998, "heldPercentInstitutions": 0.0999, "shortRatio": 1.16, "shortPercentOfFloat": 0.052800003, "impliedSharesOutstanding": 75462405, "bookValue": -1.977, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8986000, "trailingEps": -0.19, "forwardEps": -1.24, "enterpriseToEbitda": -24.585, "52WeekChange": -0.39999998, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.025, "recommendationKey": "none", "totalCash": 4473000, "totalCashPerShare": 0.059, "ebitda": -6142000, "totalDebt": 151048992, "quickRatio": 7.48, "currentRatio": 8.196, "returnOnAssets": -0.55357, "freeCashflow": -1603125, "operatingCashflow": -6790000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "longName": "Galera Therapeutics, Inc.", "epsTrailingTwelveMonths": -0.19, "epsForward": -1.24, "fiftyDayAverageChange": 0.0045800004, "fiftyDayAverageChangePercent": 0.22428994, "twoHundredDayAverageChange": -0.0017999988, "twoHundredDayAverageChangePercent": -0.06716414, "priceToBook": -0.0126454225, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1763154000, "exchange": "OQB", "messageBoardId": "finmb_225098093", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 4.1666675, "regularMarketPrice": 0.025, "marketState": "CLOSED", "shortName": "Galera Therapeutics, Inc.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1573137000000, "regularMarketChange": 0.0010000002, "regularMarketDayRange": "0.0235 - 0.0235", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 140925, "fiftyTwoWeekLowChange": 0.010000001, "fiftyTwoWeekLowChangePercent": 0.66666675, "fiftyTwoWeekRange": "0.015 - 0.06", "fiftyTwoWeekHighChange": -0.034999996, "fiftyTwoWeekHighChangePercent": -0.5833333, "fiftyTwoWeekChangePercent": -39.999996, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "displayName": "Galera Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]